Tibetan medicine regimen 1

Tibetan medicine regimen 1 is a multi-component herbal treatment protocol developed by the Tibetan Hospital Mentsee Khang of the Tibet Autonomous Region for the management of asymptomatic and mild COVID-19 (Omicron variant). The regimen is a combination of three traditional Tibetan formulations: Norbu 7 (Nuobu-Qi-Wei-San), Shiwei Longdan Hua San (Ten-ingredient Gentian Powder), and Ershiwuwei Feibing Wan (Twenty-five-ingredient Lung Disease Pill). These formulations are derived from classical Tibetan medical texts and are intended to clear heat, detoxify the body, and support respiratory function. Norbu 7 is typically used as a foundational clearing medicine, while the other components target specific symptoms associated with lung heat and inflammation. The regimen was evaluated in a prospective clinical study (ChiCTR2200063072) to assess its impact on viral shedding time, clinical efficacy, and safety in patients during the Omicron outbreak in Tibet.